Addendum to Agreement between Colorado Biolabs, Inc. and Medical Futures Inc. Dated November 19th, 2014Addendum to Agreement • August 14th, 2015 • Tribute Pharmaceuticals Canada Inc. • Pharmaceutical preparations
This ADDENDUM is attached to and forms part of the original Distribution Agreement dated December 1st, 2006 between Colorado Biolabs Inc. (CBL) and Medical Futures Inc.MFI). To the extent that any of the terms or conditions contained in this ADDENDUM may contradict or conflict with any of the terms or conditions of the original Agreement, it is expressly understood and agreed that the terms of this ADDENDUM shall take precedence and supersede the original Distribution Agreement dated December 1st, 2006.
DISTRIBUTION AGREEMENTDistribution Agreement • August 14th, 2015 • Tribute Pharmaceuticals Canada Inc. • Pharmaceutical preparations
In consideration of the promises and actions of the parties that are expressed in this Agreement, the parties agree as follows:
Amendment No. 1 to December 1, 2006 Distribution Agreement2006 Distribution Agreement • August 14th, 2015 • Tribute Pharmaceuticals Canada Inc. • Pharmaceutical preparations
This Amendment No. 1 (the “Amendment”) to the Distribution Agreement (the “Agreement”), which is dated December 1, 2006 between Colorado Bio Labs, Inc. (“CBL”) and MFI, Inc. (“MFI”) is dated as of December 1, 2010 (the “Effective Date”). This Amendment is authorized by and is being made in compliance with the second sentence of Section XI, paragraph 12 of the Agreement. Terms not otherwise defined in this Amendment have the meanings provided in the Agreement. When the letter “A” appears in front of a paragraph number of this Amendment, it means “Amendment.”
